July 7, 2020 / 11:32 AM / a month ago

BRIEF-Myriad Announces New Studies Validating Ability Of Riskscore® Test To Modify Breast Cancer Risk Prediction

July 7 (Reuters) - Myriad Genetics Inc:

* MYRIAD ANNOUNCES NEW STUDIES VALIDATING THE ABILITY OF MYRIAD’S RISKSCORE® TEST TO MODIFY BREAST CANCER RISK PREDICTION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below